Trial Profile
A Multicenter, Randomized, Open-Label, Parallel-Group Trial to Compare the Efficacy and Safety of the Sufentanil NanoTab PCA System/15 mcg (Zalviso) to Intravenous Patient-Controlled Analgesia With Morphine for the Treatment of Acute Post-Operative Pain
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Mar 2024
Price :
$35
*
At a glance
- Drugs Sufentanil (Primary) ; Morphine
- Indications Postoperative pain
- Focus Registrational; Therapeutic Use
- Sponsors AcelRx Pharmaceuticals; Talphera
- 09 Jan 2024 According to Talphera media release, AcelRx Pharmaceuticals changed its name to Talphera, Inc
- 07 Jan 2019 According to an AcelRx Pharmaceuticals media release, data from a pooled analysis from this trial alongwith several other sufentanil trials was published in the journal Pain Management.
- 14 Nov 2018 According to an AcelRx Pharmaceuticals media release,data from this study will be Presented at the 17th Annual ASRA Pain Medicine Meeting